Researchers Develop New Tool That Could Lead to Noninvasive Liquid Biopsies
Vanderbilt University
An analytical tool called EV fingerprinting could soon replace traditional invasive biopsies for certain diseases
liquid biopsy
Transforming Early Cancer Detection with Liquid Biopsy, Automation, and AI
Swathi Kodaikal, MSc
The liquid biopsy market is expected to increase by approximately 20 percent between 2022 and 2032
Novel Exosome-Based Liquid Biopsy Detects Pancreatic Cancer
American Association for Cancer Research
When combined with CA 19-9, the novel biopsy accurately detected 97 percent of stage 1–2 pancreatic cancers
Liquid Biopsy Not Effective for Colorectal Cancer Screening
American Gastroenterological Association
A blood test will be better than nothing, but may lead to more CRC cases and deaths than established screening tests
ctDNA Predicts Therapy Response in Gastroesophageal Cancer Cases
Johns Hopkins Medicine
Liquid biopsy helps screen for ctDNA, which is linked to how patients respond to immuno- and chemo-therapy
Translating New Noninvasive Screening Methodologies to Clinical Practice
Honey Reddi, PhD, FACMG
With biomarker research rapidly evolving, liquid biopsies are set to become the cornerstone of clinical cancer screening
Noninvasive Biopsies Help Detect and Monitor Neuroblastoma
Princess Máxima Center for Pediatric Oncology
The simple blood tests for childhood cancers are being tested in the clinical setting for the first time
Detecting Cancers Earlier Using ML and Fragmentomics
City of Hope
The innovative approach could help clinicians identify cancer in patients sooner and using smaller blood draws
Priming Agents Maximize ctDNA Availability for Liquid Biopsies
Massachusetts Institute of Technology
The advance makes ctDNA detection in blood samples easier, enabling earlier cancer diagnosis and treatment
Liquid Biopsy Predicts Immunotherapy Response in Lung Cancer Cases
Johns Hopkins Medicine
Through this work, researchers encourage using liquid biopsies in clinical decision-making